Author

E. Akl

h-index 20 View on Semantic Scholar

We have 3 of 84 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Frameworks for adaptation of health guidelines: a systematic survey update.

INTRODUCTION Guideline development is both time-consuming and resource-intensive, and duplication of efforts contribute to research waste. Although adopting existing guidelines is an efficient alternative, it often fails to account for contextual factors. Adapting trustworthy, previously developed relevant guidelines o...

Andrea J. Darzi, K. Torabiardakani, M. El Hajj et al. · Journal of Clinical Epidemio... · 0 citations

Review Open access Sep 2026

Evaluation and Management of Anemia in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2026 Clinical Practice Guideline.

DESCRIPTION The Kidney Disease: Improving Global Outcomes (KDIGO) 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD) provides an update of the 2012 version. Its scope includes anemia diagnosis and use of iron therapy, erythropoiesis-stimulating agents (ESAs), hypoxia-inducible...

S. Hedayati, Jodie L. Babitt, Jeffrey S. Berns et al. · Annals of Internal Medicine · 0 citations

Review Open access Jul 2026

Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta-analysis.

The aim of this living systematic review and network meta-analysis was to compare the benefits and harms of DMARDs after failure of biologic or targeted synthetic DMARDs in adults with rheumatoid arthritis and found moderate-/high-certainty evidence that using a tumour necrosis factor (TNF) inhibitor not previously tri...

Jocelyn Thomas, M. Kamso, Samuel L. Whittle et al. · Cochrane Database of Systema... · 0 citations